On 10 JUNE Palatin Technologies, Inc. (NYSEMKT: PTN) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application Serial Number 13/311,824 (the ‘824 application). The application includes composition of matter claims on a next generation of melanocortin receptor-specific peptides for sexual dysfunction, obesity, metabolic syndrome and other indications. Palatin Technologies, Inc. (NYSEMKT: PTN) weekly performance is -2.73%. On last trading day company shares ended up $1.07. Analysts mean target price for the company is $4.00. Palatin Technologies, Inc. (NYSEMKT: PTN) distance from 50-day simple moving average (SMA50) is -8.15%.
On 28 MAY IDEXX Laboratories, Inc. (NASDAQ:IDXX) announced that it will soon participate in the William Blair 34th Annual Growth Stock Conference. Jonathan Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company at the Four Seasons Hotel, Chicago, Illinois. IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares fell -0.03% in last trading session and ended the day on $130.98. IDXX Gross Margin is 55.10% and its return on assets is 19.30%. IDEXX Laboratories, Inc. (NASDAQ:IDXX) quarterly performance is 2.40%.
On 6 JUNE Neogen Corporation (NASDAQ:NEOG) reported $0.18 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.18. The company had revenue of $62.00 million for the quarter, compared to the consensus estimate of $60.38 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 21.3% on a year-over-year basis. Analysts expect that Neogen will post $0.77 EPS for the current fiscal year. Neogen Corporation (NASDAQ:NEOG) shares moved down -1.87% in last trading session and was closed at $36.78, while trading in range of $36.62 – $37.54. Neogen Corporation (NASDAQ:NEOG) year to date (YTD) performance is -19.52%.
On 21 MAY Venaxis Inc (NASDAQ:APPY) announced it will participate in the 11th Annual Craig-Hallum Institutional Investor Conference, to be held at the Minneapolis Marriott City Center. Venaxis Inc (NASDAQ:APPY) ended the last trading day at $2.26. Company weekly volatility is calculated as 4.63% and price to cash ratio as 5.43. Venaxis Inc (NASDAQ:APPY) showed a positive weekly performance of 4.63%.
On 10 JUNE Nutra Pharma Corp. (OTCMKTS: NPHC) announced that MyNyloxin.com, a new company that has the exclusive rights to market and distribute Nutra Pharma’s over-the-counter (OTC) pain reliever, Nyloxin®, has signed contracts to begin airing television commercials beginning June 23rd. The advertisements focus on the benefits of Nyloxin®. The first contract includes over 30,000 spots to run throughout the Southeast Region from Comcast and AT&T U-Verse Cable providers. Nutra Pharma Corp. (OTCMKTS: NPHC) on last trading day company shares ended up $0.0115.